Study finds ACA slowed rise in employer-sponsored premiums
A new Commonwealth Fund study finds that, following implementation of the Affordable Care Act, premiums for employer-sponsored insurance in 31 states grew more slowly than in previous years.
A new Commonwealth Fund study finds that, following implementation of the Affordable Care Act (ACA), premiums for employer-sponsored insurance in 31 states grew more slowly than in previous years.
But more costs were also shifted to employees in the form of premiums and deductibles, and by 2013, premium costs ate up more than 20% of income in 37 states, according to the study.
Premium increases from 2010 to 2013 grew three times faster than income, while per-person deductibles at least doubled in all but six states and the District of Columbia.
p
Noting that premiums in the ACA’s federal marketplace were also slower than expected, the study says the main reason for the slowdown in premium growth is a decline in healthcare spending since 2009.
Based on an analysis of claims data, the study found that families and employees had used fewer services between 2009 and 2014, including hospital care and elective surgery.
Quality initiates implemented as a part of the ACA, including alterative models of care delivery and efforts to reduce waste and duplication, might also be contributing to the slowdown in premium growth, notes the study.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More
